恶性疟原虫环子孢子蛋白四肽重复序列单克隆抗体的制备Preparation of monoclonal antibody against tetrapeptide repeated motif of malignant Plasmodium falciparum circumsporozoite protein
陆俭,李萍,马亚茹,李刚,陈勇,蒋琳
LU Jian,LI Ping,MA Ya-ru,LI Gang,CHEN Yong,JIANG Lin
摘要(Abstract):
目的制备针对恶性疟原虫环子孢子蛋白(circumsporozoite protein,CSP)NANP四肽重复序列[Asn-Ala-AsnPro(NANP)repeated motif]的单克隆抗体。方法采用马来酰亚胺修饰的BSA与(NANP)5C偶联法及ADH-EDC介导的BSA与(NANP)5偶联法,将合成的NANP多肽与载体蛋白偶联,免疫BALB/c小鼠后,采用免疫后小鼠脾细胞与骨髓瘤细胞SP2/0杂交的细胞融合技术,获得分泌抗(NANP)5多肽单克隆抗体的阳性杂交瘤细胞株,间接ELISA法检测效价。通过免疫F1小鼠诱生腹水,采用50%硫酸铵沉淀法盐析纯化后,进行单克隆抗体亚类和特异性鉴定。结果采用2种方法制备了BSA-(NANP)5偶联蛋白,以该蛋白为抗原,获得10株抗(NANP)5多肽阳性杂交瘤细胞株,效价在1∶80 000~1∶640 000之间,均为Ig G1亚类,轻链类型为κ,可被(NANP)5及CSP抗原特异性识别。结论成功制备了抗(NANP)5多肽的单克隆抗体,该抗体可在恶性疟疾疫苗的研发中发挥重要作用。
Objective To prepare the monoclonal antibody(Mc Ab) against Asn-Ala-Asn-Pro(NANP) repeated motif of circumsporozoite protein(CSP)of Plasmodium falciparum. Methods Maleimide-modified BSA was coupled with(NANP)5C, while ADH-EDC mediated BSA with(NANP)5. The synthetic NANP was coupled with carrier protein and immunized to BALB / c mice. Hybridoma cell strain secreting Mc Ab against(NANP)5 was obtained by hybridization of spleen cells of immunized mice with bone marrow hybridoma SP2 / 0 cells, determined for titer by indirect ELISA, and immunized to F1 mice. The obtained ascites was purified by precipitation with 50% ammonium sulphate, and identified for subclass and specificity. Results BSA-(NANP)5 coupling protein was prepared by two methods and used as an antigen to prepare ten hybridoma cell strains secreting Mc Abs against(NANP)5 peptide. All the Mc Abs were Ig G1 with Ⅱκ chain and titers of1 ∶ 80 000 ~ 1 ∶ 640 000, which were recognized by(NANP)5 and CSP antigen. Conclusion The Mc Ab against(NANP)5 peptide was successfully prepared, which played an important role in development of malignant malaria vaccine.
关键词(KeyWords):
疟疾;环子孢子蛋白;NANP;四肽重复序列;单克隆抗体
Malaria;Circumsporozoite protein;NANP;Tetrapeptide repeated motif;Monoclonal antibody(Mc Ab)
基金项目(Foundation):
作者(Author):
陆俭,李萍,马亚茹,李刚,陈勇,蒋琳
LU Jian,LI Ping,MA Ya-ru,LI Gang,CHEN Yong,JIANG Lin
DOI: 10.13200/j.cnki.cjb.001085
参考文献(References):
- [1]Wang YX,Cao C,Mao SX,et al.Cloning and expression of hybrid antigen of alaria Plasmolium falciparum[J].Lett in Biotechnol,2001,12(3):188-191.(in Chinese)王衣祥,曹诚,毛盛贤,等.恶性疟多抗原表位融合基因在不同载体中的克隆与表达[J].生物技术通讯,2001,12(3):188-191.
- [2]国家卫生和计划生育委员会.关于印发《中国消除疟疾行动计划(2010-2020年)》的通知[EB/OL].(2010-05-19)[2015-02-18].卫疾控发[2010]47号.http://www.moh.gov.cn/mohbgt/s10788/201005/47529.shtml.
- [3]Dame JB,Williams JL,Mc Cutchan TF,et al.Structure of the gene encoding the immunodominant surface antigen on the spotozoite of the human malaria parasite Plasmodium falciparum[J].Science,1984,225(4662):593-599.
- [4]Gerloni M,Baliou WR,Billetta R,et al.Immunity to Plasmodium falciparum malaria sporozoites by somatic transgene immunization[J].Nat Biotechnol,1997,15(9):876-881.
- [5]Gerloni M,Xiong S,Zanetti M.Durable immunity and immunologic memory to a parasite antigen induced by somatic transgene immunization[J].Vaccine,1998,16(2-3):293-297.
- [6]Kubler-Kielb J,Majadly F,Biesova Z,et al.A bicomponent Plasmodium falciparum investigational vaccine composed of protein-peptide conjugates[J].Proc Natl Acad Sci USA,2010,107(3):1172-1177.
- [7]Agnandji ST,Lell B,Soulanoudjingar SS,et al.First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children[J].N Engl J Med,2011,365(20):1863-1875.
- [8]Yang YC,Han J,Xin XF,et al.Expression and purification study of Plasmodium falciparum circumsporozoite protein with cell-free expression system[J].Chin J Pharm Anal,2011,31(7):1228-1231.(in Chinese)杨英超,韩静,辛晓芳,等.恶性疟原虫环子孢子蛋白在无细胞表达系统的表达及纯化研究[J].药物分析杂志,2011,31(7):1228-1231.
- [9]Tan YZ.Practical Techniques of Cell Culture[M].Beijing:Higher Education Press,2010:305-310.(in Chinese)谭玉珍.实用细胞培养技术[M].北京:高等教育出版社,2010:305-310.
- [10]Xiao ZH,Huang ZL,Lin YX,et al.Study on purification methods of monoclonal antibody from mouse ascites fluid[J].Chin Med Biotechnol,2013,8(6):425-428.(in Chinese)肖增鸿,黄昭亮,林月霞,等.腹水型单克隆抗体纯化方法的研究[J].中国医药生物技术,2013,8(6):425-428.
- [11]焦奎,张书圣.酶联免疫分析技术及应用[M].北京:化学工业出版社,2004:96-107.
- [12]Song SJ,Zhang X.The effect of immune approach and conjugation quantity of small molecular immunogen on the valence of antibody[J].Int J Lab Med,2011,32(10):1069-1070,1072.(in Chinese)宋世军,张旋.小分子抗原免疫途径和结合数量对抗体效价的影响[J].国际检验医学杂志,2011,32(10):1069-1070,1072.
- [13]Du L,Tan XM,Jiang Y,et al.Preparation and characteristic of typhoid Vi conjugate vaccine[J].Chin J Microbiol Immunol,2006,26(7):665-668.(in Chinese)杜琳,谭小梅,蒋奕,等.伤寒Vi结合疫苗的研究[J].中华微生物学和免疫学杂志,2006,26(7):665-668.
- [14]Hou LP,Fu HY,Tao YL,et al.Combine UV and SDS-PAGE to monitor and optimize of carbodiimide coupling method for preparing peptide immunogen[J].J Instrum Anal,2013,32(7):783-788.(in Chinese)侯利平,傅海媛,陶亚岚,等.联合UV及SDS-PAGE监测并优化碳二亚胺偶联法制备多肽免疫原[J].分析测试学报,2013,32(7):783-788.
- [15]Chen Y,Gao YH.Chemical cross linking technology used in the study of protein-protein interaction[J].Chemist of Life,2008,28(4):485-488.(in Chinese)陈勇,高友鹤.化学交联技术在蛋白质相互作用研究中的应用[J].生命的化学,2008,28(4):485-488.
- [16]Kubler-Kielb J,Majadly F,Wu Y,et al.Long-lasting and transmission-blocking activity of antibodies to Plasmodium falciparum elicited in mice by protein conjugates of Pfs25[J].Proc Natl Acad Sci USA,2007,104(1):293-298